Bumper Offer - Urjas oil Just @ Rs. 1
Urifast CP Capsule is a commercial drug that is prescribed in the form of Capsule. Primarily, it is used for the treatment of Urinary Tract Infection. Other than this, Urifast CP Capsule has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Urifast CP Capsule. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Urifast CP Capsule have been listed ahead. Usually, these side effects of Urifast CP Capsule go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Urifast CP Capsule's effect is Safe during pregnancy and Moderate for lactating mothers. Further, the section on Urifast CP Capsule related warnings talks about Urifast CP Capsule's effects on the liver, heart and kidney.
Urifast CP Capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Anemia, Liver Disease are examples of such conditions. Other contraindications of Urifast CP Capsule have been discussed in the sections ahead.
Drug reaction of Urifast CP Capsule with other medicines has been reported. See below for a complete list.
You should also be aware that Urifast CP Capsule is not safe while driving, and is not addiction.
Urifast CP Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Urifast CP Capsule safe for pregnant women?
Urifast is safe for pregnant women.
Is the use of Urifast CP Capsule safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Urifast. Immediately discontinue Urifast if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Urifast CP Capsule on the Kidneys?
Urifast has very mild side effects on the kidneys.
What is the effect of Urifast CP Capsule on the Liver?
Side effects of Urifast rarely affect the liver.
What is the effect of Urifast CP Capsule on the Heart?
Urifast has very mild side effects on the heart.
Urifast CP Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Urifast CP Capsule unless your doctor advises you to do so -
Is this Urifast CP Capsule habit forming or addictive?
Urifast CP Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Urifast CP Capsule can make you feel drowsy.
Is it safe?
Urifast CP Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Urifast CP Capsule for mental disorders.
Interaction between Food and Urifast CP Capsule
It is safe to take Urifast CP Capsule with food.
Interaction between Alcohol and Urifast CP Capsule
Drinking alcohol while on Urifast CP Capsule does not produce side effects. However, it is in your best interest to be careful.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
